GCP
SPPI

GSA Capital Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

GSA Capital Partners’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-59,677
Closed -$22K – 2047
2022
Q4 		$22K Sell
59,677
-577,895
-91% -$244K ﹤0.01% 1386
2022
Q3 		$274K Buy
+637,572
New +$626K 0.04% 993
2022
Q1 		– Sell
-410,691
Closed -$522K – 1947
2021
Q4 		$522K Sell
410,691
-322,244
-44% -$576K 0.07% 571
2021
Q3 		$1.6M Buy
732,935
+279,791
+62% +$764K 0.16% 111
2021
Q2 		$1.7M Buy
453,144
+216,668
+92% +$753K 0.19% 89
2021
Q1 		$771K Buy
236,476
+85,902
+57% +$308K 0.13% 190
2020
Q4 		$513K Buy
+150,574
New +$620K 0.08% 414
2020
Q1 		– Sell
-23,345
Closed -$85K – 1685
2019
Q4 		$85K Buy
+23,345
New +$189K 0.01% 1351
2018
Q3 		– Sell
-10,977
Closed -$230K – 1986
2018
Q2 		$230K Sell
10,977
-6,000
-35% -$111K 0.01% 1491
2018
Q1 		$273K Buy
+16,977
New +$336K 0.01% 1347
2015
Q4 		– Sell
-58,400
Closed -$349K – 2017
2015
Q3 		$349K Buy
+58,400
New +$405K 0.02% 1297
2015
Q1 		– Sell
-53,362
Closed -$370K – 2249
2014
Q4 		$370K Buy
+53,362
New +$392K 0.03% 1132

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GSA Capital Partners's SPPI Position: Q1 2023 in Review

GSA Capital Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2023, closing a stake of 59,677 shares — an estimated $22K sold.

GSA Capital Partners first reported a position in SPPI in Q4 2014 and held it in 12 quarters. The position peaked at $1.7M in Q2 2021. 69 funds tracked by Wall St. Rank hold SPPI as of Q1 2023.

  • GSA Capital Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 59,677 Spectrum Pharmaceuticals Inc shares in Q1 2023, an estimated $22K.
  • GSA Capital Partners first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 12 quarters.
  • GSA Capital Partners's Spectrum Pharmaceuticals Inc position peaked at $1.7M in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.